{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:18:31Z","timestamp":1794590311260,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Respiratory Society \u2013 Clinical Research Collaboration","award":["PROFILEnet"],"award-info":[{"award-number":["PROFILEnet"]}]},{"name":"European Respiratory Society \u2013 Clinical Research Collaboration","award":["PROFILEnet"],"award-info":[{"award-number":["PROFILEnet"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03949-7","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:04:41Z","timestamp":1761314681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fibrotic and vascular abnormalities quantified by an AI-based model are associated with outcomes in patients with idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Julien","family":"Guiot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonne","family":"Engelberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Henket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Maloir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"9","key":"3949_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"3949_CR2","doi-asserted-by":"publisher","unstructured":"Guiot J, Duysinx B, Seidel L, Henket M, Gester F, Bonhomme O, et al. Clinical experience in idiopathic pulmonary fibrosis: a retrospective study. Acta Clin Belgica Int J Clin Lab Med. 2017. https:\/\/doi.org\/10.1080\/17843286.2017.1399228.","DOI":"10.1080\/17843286.2017.1399228"},{"key":"3949_CR3","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.ejro.2020.100228","volume":"7","author":"J Widell","year":"2020","unstructured":"Widell J, Lid\u00e9n M. Interobserver variability in high-resolution CT of the lungs. Eur J Radiol Open. 2020;7:100228.","journal-title":"Eur J Radiol Open"},{"key":"3949_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.21846","volume":"42","author":"J Guiot","year":"2022","unstructured":"Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix AN, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev. 2022;42:426\u201340.","journal-title":"Med Res Rev."},{"key":"3949_CR5","doi-asserted-by":"publisher","unstructured":"Frix A-N, Cousin F, Refaee T, Bottari F, Vaidyanathan A, Desir C, et al. Personalized medicine review radiomics in lung diseases imaging: state-of-the-art for clinicians. 2021.\u00a0https:\/\/doi.org\/10.3390\/jpm11070602.","DOI":"10.3390\/jpm11070602"},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.inffus.2022.01.001","volume":"82","author":"Y Nan","year":"2022","unstructured":"Nan Y, Del Ser J, Walsh S, Sch\u00f6nlieb C, Roberts M, Selby I, et al. Data harmonisation for information fusion in digital healthcare: a state-of-the-art systematic review, meta-analysis and future research directions. Inf Fusion. 2022;82:99\u2013122.","journal-title":"Inf Fusion"},{"issue":"1","key":"3949_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/thoraxjnl-2019-213620","volume":"75","author":"G Raghu","year":"2020","unstructured":"Raghu G, Ley B, Brown KK, Cottin V, Gibson KF, Kaner RJ, et al. Risk factors for disease progression in idiopathic pulmonary fibrosis. Thorax. 2020;75(1):78\u201380.","journal-title":"Thorax"},{"issue":"10","key":"3949_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684.","journal-title":"Ann Intern Med"},{"key":"3949_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.915243","author":"T Refaee","year":"2022","unstructured":"Refaee T, Salahuddin Z, Frix AN, Yan C, Wu G, Woodruff HC, et al. Diagnosis of idiopathic pulmonary fibrosis in high-resolution computed tomography scans using a combination of handcrafted radiomics and deep learning. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.915243.","journal-title":"Front Med"},{"issue":"7","key":"3949_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1164\/rccm.202112-2684OC","volume":"206","author":"SLF Walsh","year":"2022","unstructured":"Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, et al. Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography. Am J Respir Crit Care Med. 2022;206(7):883\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3949_CR11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1148\/radiol.2463062200","volume":"246","author":"AC Best","year":"2008","unstructured":"Best AC, Meng J, Lynch AM, Bozic CM, Miller D, Grunwald GK, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology. 2008;246(3):935\u201340.","journal-title":"Radiology"},{"issue":"1","key":"3949_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.acra.2014.08.004","volume":"22","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Brown MS, Chong D, Gjertson DW, Lu P, Kim HJ, et al. Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7Months. Acad Radiol. 2015;22(1):70\u201380.","journal-title":"Acad Radiol"},{"key":"3949_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/RTI.0b013e3182a21969","author":"BJ Bartholmai","year":"2013","unstructured":"Bartholmai BJ, Raghunath S, Karwoski RA, Moua T, Rajagopalan S, Maldonado F, et al. Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging. 2013. https:\/\/doi.org\/10.1097\/RTI.0b013e3182a21969.","journal-title":"J Thorac Imaging"},{"issue":"4","key":"3949_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJMoa2008470","volume":"384","author":"A Waxman","year":"2021","unstructured":"Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, et al. Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease. N Engl J Med. 2021;384(4):325\u201334.","journal-title":"N Engl J Med"},{"key":"3949_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.930055","volume":"9","author":"J Guiot","year":"2022","unstructured":"Guiot J, Maes N, Winandy M, Henket M, Ernst B, Thys M, et al. Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity. Front Med. 2022;9:930055.","journal-title":"Front Med"},{"key":"3949_CR16","doi-asserted-by":"publisher","unstructured":"Baraghoshi D, Strand M, Humphries SM, Jos\u00e9 Est\u00e9par RS, Sanchez-Ferrero GV, Charbonnier JP, et al. Quantitative CT evaluation of emphysema progression over 10 years in the COPDGene study. Radiology. 2023;307(4).\u00a0https:\/\/doi.org\/10.1148\/radiol.222786.","DOI":"10.1148\/radiol.222786"},{"key":"3949_CR17","doi-asserted-by":"publisher","unstructured":"Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, et al. Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis.\u00a0Eur Respir J. 2019;54. https:\/\/doi.org\/10.1183\/13993003.02341-2018.\u00a0European Respiratory Society.","DOI":"10.1183\/13993003.02341-2018"},{"issue":"8","key":"3949_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/thoraxjnl-2019-213865","volume":"75","author":"J Jacob","year":"2020","unstructured":"Jacob J, Aksman L, Mogulkoc N, Procter AJ, Gholipour B, Cross G, et al. Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome. Thorax. 2020;75(8):648\u201354.","journal-title":"Thorax"},{"key":"3949_CR19","doi-asserted-by":"publisher","unstructured":"Guiot J, Walsh SLF. The ERS PROFILE.net clinical research collaboration is dedicated to the set-up of an academic network to enhance imaging-based management of progressive pulmonary fibrosis. Eur Respir J. 2023;62.\u00a0https:\/\/doi.org\/10.1183\/13993003.00577-2023.\u00a0European Respiratory Society.","DOI":"10.1183\/13993003.00577-2023"},{"key":"3949_CR20","doi-asserted-by":"publisher","unstructured":"Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, et al. Computed tomographic biomarkers in idiopathic pulmonary fibrosis: the future of quantitative analysis.\u00a0Am J Respir Crit Care Med. 2019;199:12\u201321.\u00a0https:\/\/doi.org\/10.1164\/rccm.201803-0444PP. American Thoracic Society.","DOI":"10.1164\/rccm.201803-0444PP"},{"issue":"6","key":"3949_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1164\/rccm.201711-2174OC","volume":"198","author":"J Jacob","year":"2018","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Van Moorsel CHM, Van Es HW, Van Beek FT, et al. Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis. Am J Respir Crit Care Med. 2018;198(6):767\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"3949_CR22","doi-asserted-by":"publisher","unstructured":"Shi Y, Wong WK, Goldin JG, Brown MS, Kim GHJ. Prediction of progression in idiopathic pulmonary fibrosis using CT scans at baseline: a quantum particle swarm optimization - random forest approach. Artif Intell Med. 2019;100.\u00a0https:\/\/doi.org\/10.1016\/j.artmed.2019.101709.","DOI":"10.1016\/j.artmed.2019.101709"},{"issue":"1","key":"3949_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2049-6958-7-42","volume":"7","author":"P Spagnolo","year":"2012","unstructured":"Spagnolo P, Tonelli R, Cocconcelli E, Stefani A, Richeldi L. Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. Multidiscip Respir Med. 2012;7(1):42.","journal-title":"Multidiscip Respir Med"},{"key":"3949_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1183\/09031936.00071812","volume":"43","author":"F Maldonado","year":"2014","unstructured":"Maldonado F, Moua T, Rajagopalan S, Karwoski RA, Raghunath S, Decker PA, et al. Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J. 2014;43:204\u201312.","journal-title":"Eur Respir J"},{"issue":"12","key":"3949_CR25","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/resp.14333","volume":"27","author":"SM Humphries","year":"2022","unstructured":"Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, et al. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022;27(12):1045\u201353.","journal-title":"Respirology"},{"key":"3949_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01384-2018","author":"SM Humphries","year":"2018","unstructured":"Humphries SM, Swigris JJ, Brown KK, Strand M, Gong Q, Sundy JS, et al. Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.01384-2018.","journal-title":"Eur Respir J"},{"issue":"2","key":"3949_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1513\/AnnalsATS.202301-084OC","volume":"21","author":"AS Oh","year":"2023","unstructured":"Oh AS, Lynch DA, Swigris JJ, Baraghoshi D, Dyer DS, Hale VA, et al. Deep Learning\u2013based fibrosis extent on computed tomography predicts outcome of fibrosing interstitial lung disease independent of visually assessed computed tomography pattern. Annals Am Thorac Soc. 2023;21(2):218\u201327.","journal-title":"Annals Am Thorac Soc"},{"key":"3949_CR28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01011-2016","author":"J Jacob","year":"2017","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Nair A, Karwoski R, et al. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01011-2016.","journal-title":"Eur Respir J"},{"key":"3949_CR29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00869-2018","author":"J Jacob","year":"2019","unstructured":"Jacob J, Hirani N, Van Moorsel CHM, Rajagopalan S, Murchison JT, Van Es HW, et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00869-2018.","journal-title":"Eur Respir J"},{"key":"3949_CR30","doi-asserted-by":"crossref","unstructured":"Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary Fibrosis. Vol. 17, annual review of pathology: mechanisms of disease. Annual Reviews Inc.; 2021. pp. 515\u201346.","DOI":"10.1146\/annurev-pathol-042320-030240"},{"key":"3949_CR31","doi-asserted-by":"publisher","unstructured":"George PM, Rennison-Jones C, Benvenuti G, Gupta G, Joly O, Gerry S, et al. The automated E-ILD CT algorithm is more prognostic than FVC in the serial assessment of patients with non-IPF fibrotic interstitial lung disease. A23. Leveraging imaging and biosamples to improve diagnosis and risk prediction in ILA and ILD. American Thoracic Society; 2023. pp. A1120\u20131120.\u00a0https:\/\/doi.org\/10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A1120.","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A1120"},{"key":"3949_CR32","doi-asserted-by":"publisher","unstructured":"Thillai M, Oldham JM, Ruggiero A, Kanavati F, McLellan T, Saini G, et al. Deep learning-based segmentation of CT scans predicts disease progression and mortality in IPF. Am J Respir Crit Care Med. 2024. https:\/\/doi.org\/10.1164\/rccm.202311-2185OC.","DOI":"10.1164\/rccm.202311-2185OC"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03949-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:04:43Z","timestamp":1761314683000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03949-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03949-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The OSIC protocol was submitted to the U.S. Central IRB Advarra. The IRB determined that the research project is exempt from IRB oversight. Consent to participate was waived considering the retrospective nature of the study. The study adheres to and is in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.G. has received institutional research grants from Janssen Pharmaceutica, Boehringer Ingelheim, MSD and Roche and has received consulting and honoraria fees from Boehringer Ingelheim, Janssen, BMS, GSK, Roche, AstraZeneca, Aquilon, Volition, Oncoradiomics and Chiesi and has received non-financial support for meeting attendance from AstraZeneca, Chiesi, MSD, Roche, Boehringer Ingelheim and Janssen. J.E. and J-P.C. are employees of Thirona and J-P.C. is shareholder of Thirona. R.L. has received institutional research grants from GSK, AstraZeneca and Chiesi and has received consulting fees from GSK and AstraZeneca and honoraria as lecturer from AstraZeneca and as speaker from GSK and has participated in ANDHI in practice study from AstraZeneca. D.A. Lynch has received consulting fees from Calyx Inc and Beohreinger Ingelheim and honoraria from Clinical Education Alliance and has unlicensed and assigned to institution patents US 10,706,533; US 11,468,564 and US 11,494,902. S.M. Humphries has received grants paid to institution from NHLBI, Boehringer Ingelheim and Calyx and has unlicensed and assigned to institution patents US 10,706,533; US 11,468,564; US 11,494,902; and US 11,922,626.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}